KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cognex (CGNX) Cash & Equivalents: 2009-2024

Historic Cash & Equivalents for Cognex (CGNX) over the last 16 years, with Dec 2024 value amounting to $186.1 million.

  • Cognex's Cash & Equivalents rose 24.77% to $245.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $245.9 million, marking a year-over-year increase of 24.77%. This contributed to the annual value of $186.1 million for FY2024, which is 8.17% down from last year.
  • As of FY2024, Cognex's Cash & Equivalents stood at $186.1 million, which was down 8.17% from $202.7 million recorded in FY2023.
  • Cognex's Cash & Equivalents' 5-year high stood at $269.1 million during FY2020, with a 5-year trough of $181.4 million in FY2022.
  • Its 3-year average for Cash & Equivalents is $190.0 million, with a median of $186.1 million in 2024.
  • In the last 5 years, Cognex's Cash & Equivalents surged by 56.96% in 2020 and then plummeted by 30.81% in 2021.
  • Cognex's Cash & Equivalents (Yearly) stood at $269.1 million in 2020, then slumped by 30.81% to $186.2 million in 2021, then decreased by 2.57% to $181.4 million in 2022, then climbed by 11.73% to $202.7 million in 2023, then decreased by 8.17% to $186.1 million in 2024.